Most sold healthcare stocks in Q3 2012

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2012, measured as net reductions in reported share positions from Q2 2012 into Q3 2012. Notable reductions at the top of this list include JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), ABBOTT LABORATORIES (ABT), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Explore more:

Net change in reported shares (all institutional filers) by symbol5 symbols with net change in reported shares from all institutional filers.−72.3K−54.2K−36.1K−18.1K0.00Net change in reported shares (all institutional filers)JNJMRKABTPFEBDXSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
JNJJOHNSON & JOHNSON-65,698-$2.84M01102
MRKMERCK & CO. INC.-60,260$1.91M00202
ABTABBOTT LABORATORIES-34,500$40.95K00102
PFEPFIZER INC-3,280$5.13M01102
BDXBECTON DICKINSON AND CO-100$65.47K00101

Frequently asked questions about Most sold healthcare stocks in Q3 2012

  • What are the most sold Healthcare stocks in Q3 2012?

    The most sold healthcare stocks in Q3 2012 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2012, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2012?

    Among filers in this sector, net reductions were largest in companies such as JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), ABBOTT LABORATORIES (ABT), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2012).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.